Merck says it’s working to reduce levels of cancer-causing compound in popular diabetes drugs
By Jen Christensen, CNN Pharmaceutical company Merck said that it is working to reduce levels of a cancer-causing organic compound that was found in some of its popular type 2 diabetes drugs. The compound, called nitrosamines or NTTP, can come from chemical reactions that can form in drugs during the manufacturing process. Nitrosamines are also
Continue Reading